EULAR 2014 :肥胖的风湿性关节炎患者疾病活动度更高

2014-06-18 佚名 睿医资讯

新近一项研究指出,肥胖的风湿性关节炎(RA)患者,基线时的疾病活动度比非肥胖患者更高。因而,与非肥胖患者相比,肥胖患者更可能接受较为激进的治疗方案以达到治疗目标。这解释了为什么通常而言肥胖患者病情进展更为严重,但影像学显示的关节损伤仍然较少。来自英国利物浦大学老龄化与慢性病学院的Christopher Sparks, MD在2014年欧洲抗风湿联盟(EULAR)大会上对这项

新近一项研究指出,肥胖的风湿性关节炎(RA)患者,基线时的疾病活动度比非肥胖患者更高。因而,与非肥胖患者相比,肥胖患者更可能接受较为激进的治疗方案以达到治疗目标。这解释了为什么通常而言肥胖患者病情进展更为严重,但影像学显示的关节损伤仍然较少。来自英国利物浦大学老龄化与慢性病学院的Christopher Sparks, MD在2014年欧洲抗风湿联盟(EULAR)大会上对这项研究的结果进行了汇报。

这项横断面研究的数据来源于Meteor基金会国际RA数据库中的3534例患者。在这些患者中,1553例为早期RA(病程<12个月),1981例确诊RA。研究者们按照体重指数(BMI)将患者分成以下几组:体重过轻(<18.5 kg/m2)、正常体重(18.5 - 24.9 kg/m2)、超重(25.0 - 25.9 kg/m2)、I度肥胖(30.0 - 34.9 kg/m2)、II度肥胖(≥35 kg/m2)。

通过对28个关节的疾病活动度进行评分(DAS28),与正常体重者相比,体重过轻和II度肥胖者疾病活动度较高的可能性至少翻倍;I度肥胖者相关可能性为1.5倍。此外,体重过轻、I度肥胖和II度肥胖患者,其具有较高水平残疾状况的可能性也高于正常体重患者。

早期RA和确诊RA患者中的观察结果相似。

疾病活动度的增高多与基线时血液的炎症反应水平较高及基线时自我报道的总体健康状况受损严重有关。一种可能的解释是,肥胖患者RA病情更严重是因为脂肪因子可加重全身炎症反应。

由于体重过轻组患者数量较少,因而其脂肪因子与全身炎症反应间的相关性尚不明确。究竟是因为持续炎症反应导致其体重过轻,还是体重过轻者疾病活动度增高的风险较高?这一问题仍无定论。

由于这是一项横断面研究,研究者认为要明确身体组成与RA间的关系,还需更为长期的数据资料。

EULAR科学项目主席、德国吉森大学风湿学教授Ulf Müller-Ladner, MD表示,间质组织与脂肪细胞中的脂肪因子促进炎症反应,可导致关节损伤情况恶化。这于是成为鼓励超重及肥胖RA患者减轻体重的另一个绝佳的理由。“越胖则疾病预后越差,” Ulf Müller-Ladner, MD称:“如果脂肪含量较少,则意味着体内炎症反应较少,关节损伤较轻。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]
    2014-06-20 lmm397
  5. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]
    2014-06-20 muzishouyi
  6. [GetPortalCommentsPageByObjectIdResponse(id=1924387, encodeId=06cf192438e70, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Sep 28 18:15:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756027, encodeId=f6921e5602725, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Nov 04 04:15:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799445, encodeId=9d511e99445f7, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Mar 03 21:15:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265208, encodeId=a0c312652088b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455318, encodeId=27e414553182b, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483372, encodeId=9b9014833e272, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Fri Jun 20 00:15:00 CST 2014, time=2014-06-20, status=1, ipAttribution=)]

相关资讯

JAMA:抗风湿生物制剂或不增加恶性肿瘤风险

9月5日,《美国医学会杂志》(JAMA)发表的一项Meta分析显示,与安慰剂或其他缓解疾病抗风湿药(DMAD)相比,使用生物制剂治疗类风湿性关节炎(RA)并不会增加患者发生恶性肿瘤的风险。 这项Meta分析由德克萨斯大学M.D. Anderson癌症中心的Maria A. Lopez-Olivo博士及其同事进行,共纳入63项为期至少24周的随机临床试验,涉及29,423例RA成人患者,目的是评价

吃鱼有助降低关节炎风险

鱼肉中含有多种对人体有益的营养物质。一项最新研究显示,如果长期通过吃鱼摄入名为“欧米伽-3”的多元不饱和脂肪酸,可显著降低患风湿性关节炎的风险。 英国新一期医学杂志《风湿性疾病纪事》刊登论文说,瑞典卡罗琳医学院研究人员对出生于1914年至1948年的3.2万名女性进行了长期跟踪调查,分析了她们的饮食习惯和健康状况等。结果发现,如果平均每天摄入“欧米伽-3”多元不饱和脂肪酸0.21克以上,

ACR:20年来风湿性关节炎的死亡率仍较高

风湿性关节炎(RA)患者比普通人的死亡率更高,这一情况从1990年到现在,一直未能改变。2月份在线发表于Arthritis Care & Research上的一篇文献对于这一现象进行了报道。 来自英国的write J. H. Humphreys及其同事在文章中指出,在自身抗体阳性的患者中,死亡率尤其高。 尽管RA早期患者的死亡率有所下降,但在普通人群中,死亡率也有所下降。 研究证实,

Arthr & Rheu:风险评分可预测风湿性关节炎病人患严重感染几率

风湿性关节炎(Rheumatoid arthritis)不仅仅使患者痛苦、使患者残疾,而且可以引发患者高的死亡风险。对于感染的高度敏感性以及伴随着自体免疫障碍是该病高死亡风险的一个原因。近日来自梅奥诊所的研究者发现了,风险评分可以用来预测病人患严重感染的几率,这项评分的信息包括:风湿性关节炎如何影响病人、病人的年龄、皮质类固醇的使用以及其它疾病是否存在等。 相关研究成果刊登在了国际著名杂志Art

Rheumatology:风湿性关节炎二线生物疗法,更换药物种类优于同类药物更换

一项意大利研究报告,对TNF抑制剂无应答的风湿性关节炎患者,更换不同作用机制的药物相比于更换为另一种抗TNF药物,可取的更好的预后。 约三分之一风湿性关节炎患者使用抗TNF制剂治疗不能产生充分应答,但在首治药物治疗失败后,选择哪种治疗方式更为合适,这一点仍尚未明确。 来自米兰大学的Dr. Ennio Giulio Favalli及其同事研究了二线生物疗法的治疗失败时间,对两种治疗策略——更换为

美国风湿病学会 2013 :及时有效的治疗可减少风湿性关节炎患者2年后的致残率

纽约新近一项研究指出,风湿性关节炎的治疗烟雾可大幅增加患者2年后关节损伤和发生残疾的可能性。相关研究结果将在10月28日圣地亚哥美国风湿病学会/美国风湿病卫生专业人员协会上发表。 “我们需要对风湿性关节炎的患者进行相关教育。一些患者因为害怕而延误治疗。他们并未把这一疾病记在心上,或不愿意开始药物治疗。一些患者仅采用非药物方法,但多数非药物疗法作用有限,”研究的主导者Bykerk博士说。 “不幸